Pittsboro biotech raises money
Biolex Therapeutics, which earlier this year scrapped plans to sell stock to the public, has rebounded in a big way by raising $60 million from private investors.... [more]
Biolex Therapeutics, which earlier this year scrapped plans to sell stock to the public, has rebounded in a big way by raising $60 million from private investors.... [more]
